Synthesis of piperazine sulfonamide analogs as diabetic-II inhibitors and their molecular docking study

Add time:07/18/2019    Source:sciencedirect.com

Piperazine Sulfonamide analogs (1–19) have been synthesized, characterized by different spectroscopic techniques and evaluated for α-amylase Inhibition. Analogs 1–19 exhibited a varying degree of α-amylase inhibitory activity with IC50 values ranging in between 1.571 ± 0.05 to 3.98 ± 0.397 μM when compared with the standard acarbose (IC50 = 1.353 ± 0.232 μM). Compound 1, 2, 3 and 7 showed significant inhibitory effects with IC50 value 2.348 ± 0.444, 2.064 ± 0.04, 1.571 ± 0.05 and 2.118 ± 0.204 μM, respectively better than the rest of the series. Structure activity relationships were established. Molecular docking studies were performed to understand the binding interaction of the compounds.

We also recommend Trading Suppliers and Manufacturers of 1-(2-BROMOPHENYL)PIPERAZINE (cas 1011-13-8). Pls Click Website Link as below: cas 1011-13-8 suppliers

Prev:Inhibition of monoamine oxidase by two substrate-analogues, with different preferences for 5-hydroxytryptamine neurons
Next:Synthesis and biological evaluation of estrone 3-O-ether derivatives containing the piperazine moiety)